NanoSyrinx

About:

NanoSyrinx is a discovery stage biotechnology company based at the University of Warwick’s Medical School.

Website: https://www.nanosyrinx.com/

Twitter/X: nanosyrinx

Top Investors: Eli Lilly, Future Planet Capital, Business Growth Fund, Octopus Ventures, Jonathan Milner

Description:

NanoSyrinx is an emerging biotechnology company developing a novel system for targeted delivery of therapeutic proteins and peptides direct to the cytosol. We are using synthetic biology approaches to develop a completely novel method for targeted drug delivery of therapeutic proteins and peptides, to the interiors of cells, to improve efficacy, safety, and economy.